Global /United States /Healthcare /Drug Manufacturers - General /ONPH

Oncology Pharma Inc.

ONPH

• OTCMKTS: ONPH • Delayed

0.0750USD 5.5%

As of 16 June 2026, Oncology Pharma Inc. has a market cap of $1.37M USD, ranking #46261 globally and #5870 in the United States. It ranks #4102 in the Healthcare sector, and #1309 in the Drug Manufacturers - General industry.

Global Rank

46261

Country Rank

5870

Sector Rank

4102

Industry Rank

1309

Key Stats

Market Cap

$1.37MUSD

Revenue (TTM)

$10.21KUSD

EBITDA (TTM)

-$8.65KUSD

Net Income (TTM)

$186.04KUSD

EBITDA Margin

-85%

Profit Margin

2K%

PE Ratio

15.6

PS Ratio

283.9

PB Ratio

-13.2

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

George Malesek open_in_new

Employees

Founded

1993

Website

oncology-pharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
5.5%	1.6%	-6.6%	1K%	3K%	2K%	71K%	-56%	-100%

News

Markets

Exchange	Ticker	Price	Quotes
OTC Markets (OTCMKTS / OTC) MIC: OTCM PRIMARY	ONPH Oncology Pharma Inc ISIN: US68235J2015 Shares Out.: Shares Outstanding: 27.388M¹ Shares Float: 15.222M² TV: TradingView: OTC: ONPH SA: Stock Analysis: OTC: ONPH YF: Yahoo Finance: ONPH GF: Google Finance: OTCMKTS: ONPH BA: Barron's: ONPH MS: Morningstar: PINX: ONPH	0.0750 USD	TV: TradingView: OTC: ONPH SA: Stock Analysis: OTC: ONPH YF: Yahoo Finance: ONPH GF: Google Finance: OTCMKTS: ONPH BA: Barron's: ONPH MS: Morningstar: PINX: ONPH

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Oncology Pharma Inc.

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.

Similar Companies

Industry: Drug Manufacturers - General (United States)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 56M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 40M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 26M%	97.4	United States
Merck & Co., Inc. NYSE: MRK	$274.03B 20M%	15.1	United States
Pfizer Inc. NYSE: PFE	$149.38B 11M%	19.5	United States
Bristol-Myers Squibb Co. NYSE: BMY	$117.58B 9M%	16.8	United States

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Roche Holding AG SIX: RO	$322.73B 256.25B CHF 24M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.3B 215.59B GBP 21M%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.68B 218.9B CHF 20M%	20.5	Switzerland
Novo Nordisk A/S CPH: NOVO-B	$182.39B 1.18T DKK 13M%	11.5	Denmark
Sanofi EPA: SAN	$110.46B 95.26B EUR 8M%	19.9	France
GSK plc LSE: GSK	$108.64B 80.96B GBP 8M%	14.6	United Kingdom

chevron_leftBack